A laboratory study evaluated the effect of Olus® AC34 on bacterial growth using complementary in vitro methods.
As the poultry industry reduces its reliance on routine antibiotics, maintaining gut health and managing enteric challenges remain important priorities. Monoglycerides are receiving increasing attention as a nutritional tool in this area, and a new in vitro study on Olus® AC34 provides additional laboratory data on its interaction with selected bacteria.
In vitro studies are used to characterize how a formulation interacts with microorganisms under controlled conditions. They can show whether concentration and contact time influence the observed response.
Olus® AC34 was tested against Salmonella gallinarum and avian pathogenic Escherichia coli (APEC) using four complementary assessments: agar well diffusion, qualitative bactericidal recovery assessment, and a time-kill assay.